The Cigna Group (NYSE:CI) Stock Position Increased by English Capital Management LLC

English Capital Management LLC boosted its position in The Cigna Group (NYSE:CI - Free Report) by 6.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,586 shares of the health services provider's stock after purchasing an additional 1,202 shares during the quarter. The Cigna Group comprises 4.3% of English Capital Management LLC's investment portfolio, making the stock its 7th biggest position. English Capital Management LLC's holdings in The Cigna Group were worth $5,685,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Focused Investors LLC grew its holdings in shares of The Cigna Group by 8.8% during the fourth quarter. Focused Investors LLC now owns 587,450 shares of the health services provider's stock worth $162,218,000 after purchasing an additional 47,550 shares in the last quarter. KLP Kapitalforvaltning AS bought a new stake in The Cigna Group during the fourth quarter valued at approximately $51,589,000. AXQ Capital LP bought a new stake in The Cigna Group during the fourth quarter valued at approximately $422,000. Hillsdale Investment Management Inc. grew its stake in The Cigna Group by 4.4% in the 4th quarter. Hillsdale Investment Management Inc. now owns 2,390 shares of the health services provider's stock worth $660,000 after buying an additional 100 shares in the last quarter. Finally, Mizuho Securities USA LLC increased its holdings in shares of The Cigna Group by 45.4% in the 4th quarter. Mizuho Securities USA LLC now owns 26,363 shares of the health services provider's stock worth $7,280,000 after buying an additional 8,236 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Remove Ads

Insider Buying and Selling

In other The Cigna Group news, insider Noelle K. Eder sold 9,944 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $320.00, for a total value of $3,182,080.00. Following the completion of the transaction, the insider now owns 13,406 shares in the company, valued at approximately $4,289,920. This represents a 42.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Elder Granger sold 2,376 shares of the business's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $310.35, for a total transaction of $737,391.60. Following the sale, the director now owns 5,471 shares in the company, valued at approximately $1,697,924.85. This trade represents a 30.28 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,751 shares of company stock valued at $13,603,991 over the last three months. Corporate insiders own 0.60% of the company's stock.

Analyst Ratings Changes

CI has been the subject of a number of research analyst reports. Royal Bank of Canada set a $355.00 price objective on shares of The Cigna Group in a report on Friday, January 31st. Sanford C. Bernstein lowered The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 price target for the company. in a research note on Thursday, February 6th. Wells Fargo & Company reduced their price objective on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a research report on Tuesday, February 4th. Truist Financial reduced their target price on shares of The Cigna Group from $390.00 to $375.00 and set a "buy" rating on the stock in a report on Tuesday, February 4th. Finally, Cantor Fitzgerald boosted their price target on shares of The Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a research note on Thursday, March 20th. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, The Cigna Group currently has a consensus rating of "Buy" and an average target price of $373.25.

The Cigna Group Trading Down 1.2 %

CI traded down $3.76 during midday trading on Tuesday, reaching $316.64. 1,051,830 shares of the company's stock traded hands, compared to its average volume of 1,564,847. The stock has a market capitalization of $86.66 billion, a price-to-earnings ratio of 25.87, a P/E/G ratio of 0.98 and a beta of 0.53. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The firm has a fifty day moving average of $301.62 and a two-hundred day moving average of $314.45. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the previous year, the business posted $6.79 earnings per share. On average, equities analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 20th. Investors of record on Wednesday, March 5th were given a dividend of $1.51 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $6.04 annualized dividend and a dividend yield of 1.91%. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. The Cigna Group's payout ratio is currently 49.35%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.